A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion

D Dersh, J Hollý, JW Yewdell - Nature Reviews Immunology, 2021 - nature.com
The remarkable success of immune checkpoint inhibitors demonstrates the potential of
tumour-specific CD8+ T cells to prevent and treat cancer. Although the number of lives …

Alternative tumour-specific antigens

CC Smith, SR Selitsky, S Chai, PM Armistead… - Nature Reviews …, 2019 - nature.com
The study of tumour-specific antigens (TSAs) as targets for antitumour therapies has
accelerated within the past decade. The most commonly studied class of TSAs are those …

[HTML][HTML] MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing

TJ O'Donnell, A Rubinsteyn, U Laserson - Cell systems, 2020 - cell.com
Computational prediction of the peptides presented on major histocompatibility complex
(MHC) class I proteins is an important tool for studying T cell immunity. The data available to …

A large peptidome dataset improves HLA class I epitope prediction across most of the human population

S Sarkizova, S Klaeger, PM Le, LW Li, G Oliveira… - Nature …, 2020 - nature.com
Prediction of HLA epitopes is important for the development of cancer immunotherapies and
vaccines. However, current prediction algorithms have limited predictive power, in part …

NetMHCpan-4.0: improved peptide–MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data

V Jurtz, S Paul, M Andreatta, P Marcatili… - The Journal of …, 2017 - journals.aai.org
Cytotoxic T cells are of central importance in the immune system's response to disease.
They recognize defective cells by binding to peptides presented on the cell surface by MHC …

Noncoding regions are the main source of targetable tumor-specific antigens

CM Laumont, K Vincent, L Hesnard… - Science translational …, 2018 - science.org
Tumor-specific antigens (TSAs) represent ideal targets for cancer immunotherapy, but few
have been identified thus far. We therefore developed a proteogenomic approach to enable …

[HTML][HTML] Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction

M Müller, F Huber, M Arnaud, AI Kraemer, ER Altimiras… - Immunity, 2023 - cell.com
The accurate selection of neoantigens that bind to class I human leukocyte antigen (HLA)
and are recognized by autologous T cells is a crucial step in many cancer immunotherapy …

Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

D Chowell, C Krishna, F Pierini, V Makarov, NA Rizvi… - Nature medicine, 2019 - nature.com
Functional diversity of the highly polymorphic human leukocyte antigen class I (HLA-I) genes
underlies successful immunologic control of both infectious disease and cancer. The …

The peptide vaccine of the future

A Nelde, HG Rammensee, JS Walz - Molecular & cellular proteomics, 2021 - ASBMB
The approach of peptide-based anticancer vaccination has proven the ability to induce
cancer-specific immune responses in multiple studies for various cancer entities. However …

Most non-canonical proteins uniquely populate the proteome or immunopeptidome

MVR Cuevas, MP Hardy, J Hollý, É Bonneil, C Durette… - Cell reports, 2021 - cell.com
Combining RNA sequencing, ribosome profiling, and mass spectrometry, we elucidate the
contribution of non-canonical translation to the proteome and major histocompatibility …